Date: Friday 17th March 2023 Time: 13:00-14:00 GMT Speakers: Christine Fletcher (GSK), Christy Mazzarisi (Mersana) and Paul Frewer (AstraZeneca).
Who is this event intended for? Anyone interested in learning about or developing leadership skills in the modern day hybrid working world. What is the benefit of attending? This session will cover the successes, challenges and changes needed by our leaders and managers in order to best support the changing workforce, whether that be in the office, remote working or a combination of the two.
Registration
Registration for this webinar is free, and is now open to Members of PSI and Non-Members. We'd love for you to join us!
To register for this event, please click here.
Overview
This PSI Lunch & Learn series focuses on career-related topics through a panel discussion, hosted by Claire Brittain & Chetan Mistry.
Upcoming session: In the upcoming event - "Modern Leaders: Remote not Distant" - we will be discussing the need for a conscious evolution of leadership styles as remote working becomes commonplace.
Whilst there has been a lot of debate on office-based vs. remote workers, there has been less discussion on what 'good' leadership looks like in the new working world. This panel discussion will explore how leaders in our industry have had to adapt, adjust and evolve in order to remain effective in their roles.
Speaker details
Speaker
Biography
Christy Mazzarisi
Innovative and accomplished Quality Systems Professional with a broad background in Pharmaceutical and Laboratory sciences with over 17 years industry practice. Overall background includes building and leading global teams across functions in the biotech and pharmaceutical space. She is passionate about continuous improvement activities and consistently building quality into each area of our lives by providing coaching, mentoring and professional support to team members, employees, and many others across industries who want to develop their leadership skills. Chair of Women in Quality group for the American Society for Quality, where she supports building the female leadership pipeline and building the future of success across various industries (automotive, aerospace, manufacturing, technology, etc.) Advocate and Gala Committee Member for the Tourette’s Association of America, Advocate for Make-A-Wish NJ and Powershift Ambassador for Shark Tank’s Daymond John.
Paul Frewer
Paul has been a statistician in the industry for over 25 years, working for Eli Lilly, GSK, Ipsen and AstraZeneca. His initial experiences were as a statistician on post-marketing studies and since then has slowly moved backwards through the phases to his current role in early clinical development.He has worked across most therapeutic areas and has specialized solely in oncology for the past 15 years. He joined AstraZeneca in 2012 and is now a Biometrics Team Leader in the Early Oncology Statistics team. He supports multiple different compounds in the oncology therapeutic area across many studies from Phase I up to Phase IIb. He has published on the AZ decision making framework and presented several times on the topic at conferences over the last few years.
Chrissie Fletcher
Chrissie is the Vice President of Speciality and Primary Care Statistics at GSK. She has worked in the Pharmaceutical Industry for over 30 years and has experience of developing and commercialising new medicines in a variety of clinical disease areas across all phases of clinical development. Chrissie is actively engaged in statistical societies, pharmaceutical trade associations and initiatives relating to the Pharmaceutical Industry such as driving innovation in clinical trials and sharing implementation experiences of the estimand framework. She is an advocate and champion for diversity, equity and inclusion where she supports a variety of Women Leadership programs.
Joint PSI/EFSPI Visualisation SIG 'Wonderful Wednesday' Webinars
Our monthly webinar explores examples of innovative data visualisations relevant to our day to day work. Each month a new dataset is provided from a clinical trial or other relevant example, and participants are invited to submit a graphic that communicates interesting and relevant characteristics of the data.
PSI Book Club: Change: How organisations achieve hard-to-image results in uncertain and volatile times
Organizations have to adapt to the transforming landscape of our industry to ensure they continue to be successful in the future. Many of us are feeling the impact of organizational change. By reading John P Kotter’s book we can understand about organizational change and learn how to thrive, rather than just survive, through change.
Change, by John P Kotter (and his team), is a summary of all that he has learned over his decades of research and leading change. His book describes why many current approaches to change are inadequate and explains why new solutions need to give people a voice and a role in a new, change-embracing organization.
Develop your understanding of organisational change and become empowered to be part of your organisation’s change, by reading Change by John P Kotter and joining the Sept-Dec 2025 book club. You will be invited to join facilitated discussions of the concepts and ideas and apply knowledge from the book in-between sessions.
PSI Book Club: Another Door Opens – Book Club Special Event
This is a Book Club Special Event in response to the changes in our industry and as a supportive move to create community and connection for those navigating redundancy and uncertainty. Read the book in advance of the book club session then join the zoom call to discuss ideas. There will be breakout groups to connect with others, exchange experiences of how the book has helped, and offer support.
Our monthly webinar series allows attendees to gain practical knowledge and skills in open-source coding and tools, with a focus on applications in the pharmaceutical industry.
This networking event is aimed at statisticians that are new to the pharmaceutical industry who wish to meet colleagues from different companies and backgrounds.
PSI Training Course: Propensity Scores: Practical Application in Non-randomised Studies
The course will introduce the topic of propensity scores and the use of external data. Covering the topics of matching and weighting as well as more advance topics of high dimension propensity scores, multi-valued treatments, double robustness and time-varying scenarios. There will be the opportunity to participate in some hands on practical exercises in R.
This two-afternoon virtual course provides a practical introduction to adaptive clinical trials, focusing on the concepts, applications, and regulatory principles outlined in ICH E20 through real-world examples and case studies.
PSI Careers - MEDMathS: Medicine Empowered by Data, Maths and Statistics
Date: Wednesday 4th November 2026
A careers talk about medical statistics and how it plays a crucial role in developing new medicines. Learn about the field of medical statistics and how it plays a crucial role in developing groundbreaking new medicines, vaccines and healthcare products.
Date: 18 November 2026
This is an excellent opportunity for students to find out more about the field of medical statistics, talk to people from different organisations and make contacts for the future. All students currently studying for a mathematics or statistics-related BSc, MSc or PhD are invited to attend, and we welcome interest from exhibitors too.
This networking event is aimed at statisticians that are new to the pharmaceutical industry who wish to meet colleagues from different companies and backgrounds.
Bristol Myers Squibb - Director, Statistical Methodology and Innovation
Lead the development of innovative statistical methods, provides expert consulting, oversees tools and software, and mentors team members while collaborating cross-functionally to address complex drug development challenges.
nQuery (Statistical Solutions) - Research Biostatistian
We're looking for a Biostatistician who thrives at the intersection of academic rigour and real-world software impact with a strong grounding in statistics and hands-on experience in biostatistics, clinical trials, or a closely related field
As a Senior Statistician, you will provide high-quality statistical support to one of our key-FSP clients. At Senior level you may also take on a supervisory role (e.g. line management and/or project management), depending on your experience and interest.
This position is deal for a statistician who values ownership, collaboration, and using data to enable confident development decisions and to support regulatory submissions.